CHEK2 and neuroblastoma: Pugh et al. [2] evaluated 240 neuroblastoma tumors and matched blood samples by genome sequencing, identifying 3 (1.2%) individuals with CHEK2 germline variants (p.Arg145Trp, p.Arg181His, and p.Arg180His).